|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
03689 KANGHUA HEALTH
Nominal 
2.170 0.000 (0.000%) | 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Turnover | 981,535 | -0.303% | 2,055,670 | 2,041,858 | 1,845,633 | 1,953,944 |
| Cost of Sales | (823,002) | -1.804% | (1,733,797) | (1,677,488) | (1,584,283) | (1,601,196) |
| Gross Profit | 158,533 | 8.288% | 321,873 | 364,370 | 261,350 | 352,748 |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | ||
| Change in FV & Impairment on Inv. Prop. | (300) | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | (10,209) | 215.482% | (4,277) | (2,768) | (4,210) | (18,443) | |
| Profit / (Loss) on Disposal | 19,208 | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (18,358) | -- | 0 | 0 | 0 | 0 | |
| Profit / (Loss) before Taxation | 52,984 | -- | 63,055 | 153,429 | 69,309 | 129,209 | |
| Taxation | (20,413) | -5.307% | (52,582) | (62,406) | (43,025) | (62,284) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 9,071 | 77.341% | 4,864 | 30,039 | 33,413 | 27,382 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 41,642 | -- | 15,337 | 121,062 | 59,697 | 94,307 | |
| 2025/06 - Interim RMB(K¥) | %Chg (Compare to Interim) | 2024/12 RMB(K¥) | 2023/12 RMB(K¥) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | |
| Net Finance Costs / (Income) | 5,825 | -57.945% | 17,627 | 7,137 | 11,817 | 17,943 |
| Depreciation & Amortisation | 69,535 | -7.383% | 149,855 | 143,079 | 149,441 | 149,443 |
| Directors' Emoluments | -- | -- | 3,625 | 2,493 | 3,103 | 3,040 |
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified |
Market Valuation Indicators
| 2025/06 - Interim | %Chg (Compare to Interim) | 2024/12 | 2023/12 | 2022/12 | 2021/12 | |
| EPS (cts) | 12.500 | -- | 4.600 | 36.200 | 17.900 | 28.200 |
| DPS (cts) | 0.000 | -- | 15.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | 326.087% | -- | -- | -- |
| Cash flow per share ($) | -- | -- | 0.838 | 0.611 | 0.662 | 0.997 |
| NBV per share ($) | 4.340 | -- | 4.305 | 4.259 | 4.483 | 4.267 |
| Remarks: | Real time quote last updated: 11/09/2025 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 41,642 |
| %Change | -- |
| EPS / (LPS) | RMB 0.125 |
| NBV Per Share (¥) | RMB 4.340 |